Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Slothman2on Oct 17, 2018 5:50pm
77 Views
Post# 28822742

RE:RE:RE:RE:RE:RE:Back to reality Stocks over priced!

RE:RE:RE:RE:RE:RE:Back to reality Stocks over priced!STZ went in for 4 billion dollars for a 38% stake in Canopy prior to them seeing a doliar of revenue from rec sales...Constellation also has the ability to buy up to 139.7 million in new shares, which represents up to $5 billion in additional funding over 3 years, where Canopy expressed an interest in a stock split...that would still make a 9 billion dollar investment for 50% of the company...what the fack is your troll a$$ seriously going on about? Constellation seems to be totally fine thinking that Canopy is worth 20 billion...you're just a troll crying the same song over and over and over. Again, you are what makes this board so useless.

blackace wrote: STZ got in around $40.  Enough said.


Bullboard Posts